Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Imaging of [18F]4F-MHPG and [18F]3F-PHPG in Healthy Volunteers
NCT02385877Phase 1Completed
- Sponsor
- University of Michigan
- Start
- Mar 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of [18F]4F-MHPG and 3-[18F]fluoro-para-hydroxyphenethylguanidine in autonomic nervous system disorders, sponsored by University of Michigan. Started Mar 2015; status: completed.
02
Drugs
[18F]4F-MHPG3-[18F]fluoro-para-hydroxyphenethylguanidine
03
Conditions
autonomic nervous system disorders
Beyond the preview
Go deeper on NCT02385877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02385877.